Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Sage Journals HomeSage Journals Home
loading
GAO Criticizes FDA on Drug Safety: FDA Extends Indications for Erbitux: First Generic rDNA Product Approved in Europe: Safety Data to Be Required in Electronic Form: Report Card on Postmarketing Studies: International Guidelines Proposed for Stem Cell Research: France Chided for Tardiness in GM Legislation